Širdies magnetinio rezonanso tyrimo įvadinis kursas
Papildoma informacija
| Tema | Trukmė |
|---|---|
| Fizikos pagrindai, saugumas, prietaisai ir širdies MR tyrimo metodika | 24.00 val. |
| Išeminės širdies ligos MR diagnostika | 80.00 val. |
| Neišeminės kilmės širdies ligų (kardiomiopatijų, miokardito) MR diagnostika, MR tyrimas taikant širdį resinchronizuojantį gydymą | 128.00 val. |
| Perikardo ligų MR diagnostik | 48.00 val. |
| Stambiųjų kraujagyslių ligų MR diagnostika | 48.00 val. |
| Širdies vožtuvų ydų MR diagnostika | 60.00 val. |
| Įgimtų širdies ydų MR diagnostika | 60.00 val. |
| Širdies darinių ir užširdinių radinių MR diagnosti- ka | 32.00 val. |
| Dėstytojas | Teorijos val. | Praktikos val. |
|---|---|---|
| Antanas Jankauskas | ||
| Tomas Lapinskas | ||
| Lina Padervinskienė | ||
| Audronė Vaitiekienė |
3 mėnesių trukmės kursą sudarys i) paskaitos – seminarai (132 val.); ii) praktiniai užsiėmimai (20 val. per savaitę), kuriuos sudarys dalyvavimas MR tyrimų atli-kimo ir vertinimo metu; iii) savarankiškas darbas – specialistas eksperto priežiūroje turės įvertinti nemažiau kaip 150 širdies MR tyrimų.
Medicininį chalatą
Kurso dalyvių skaičius grupėje: 1–2
Cardiovascular magnetic resonance physics for clinicians: part I. Ridgway JP. J Cardi-ovasc Magn Reson. 2010 Nov 30;12:71. doi: 10.1186/1532-429X-12-71.
2. 2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry. Bruder O, Schneider S, Pilz G, van Rossum AC, Schwitter J, Nothnagel D, Lombardi M, Buss S, Wagner A, Petersen S, Greulich S, Jensen C, Nagel E, Sechtem U, Mahrholdt H. J Cardiovasc Magn Reson. 2015 Jul 14;17:58. doi: 10.1186/s12968-015-0168-3.
3. Quantification of LV function and mass by cardiovascular magnetic resonance: multi-center variability and consensus contours. Suinesiaputra A, Bluemke DA, Cowan BR, Friedrich MG, Kramer CM, Kwong R, Plein S, Schulz-Menger J, Westenberg JJ, Young AA, Nagel E. J Cardiovasc Magn Reson. 2015 Jul 28;17(1):63. doi: 10.1186/s12968-015-0170-9.
4. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. Kra-mer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Mag-netic Resonance Board of Trustees Task Force on Standardized Protocols. J Cardiovasc Magn Reson. 2013 Oct 8;15:91. doi: 10.1186/1532-429X-15-91.
5. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. J Cardiovasc Magn Re-son. 2016 Jan 22;18:6. doi: 10.1186/s12968-016-0225-6.
6. Normal values for cardiovascular magnetic resonance in adults and children. Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EB, Wil-liams R, Plein S, Tee M, Eng J, Bluemke DA. J Cardiovasc Magn Reson. 2015 Apr 18;17:29. doi: 10.1186/s12968-015-0111-
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, Dill T, Larsson HB, Flamm SD, Marquardt M, Johansson L. Eur Heart J. 2008 Feb;29(4):480-9.
MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a compara-tive multicentre, multivendor trial. Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schönberg SO, Luchner A, Strohm O, Ahlstrom H, Dill T, Hoebel N, Simor T; MR-IMPACT Investigators. Eur Heart J. 2013 Mar;34(10):775-81.
9. Comparison of cardiovascular magnetic resonance and single-photon emission com-puted tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Tri-al. Greenwood JP, Motwani M, Maredia N, Brown JM, Everett CC, Nixon J, Bijsterveld P, Dickinson CJ, Ball SG, Plein S. Circulation. 2014 Mar 11;129(10):1129-38.
10. EACVI appropriateness criteria for the use of cardiovascular imaging in heart failure derived from European National Imaging Societies voting. Garbi M, Edvardsen T, Bax J, Petersen SE, McDonagh T, Filippatos G, Lancellotti P; Reviewer panel. Eur Heart J Car-diovasc Imaging 2016 Jul 17(7):711-21. doi: 10.1093/ehjci/jew081. Epub 2016 Apr 29.
11. Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected My-ocarditis: The MyoRacer-Trial. Lurz P, Luecke C, Eitel I, Föhrenbach F, Frank C, Gro-thoff M, de Waha S, Rommel KP, Lurz JA, Klingel K, Kandolf R, Schuler G, Thiele H, Gutberlet M. J Am Coll Cardiol. 2016 Apr 19;67(15):1800-11. doi: 10.1016/j.jacc.2016.02.013.
12. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype. El-lims AH, Iles LM, Ling LH, Chong B, Macciocca I, Slavin GS, Hare JL, Kaye DM, Marasco SF, McLean CA, James PA, du Sart D, Taylor AJ. Eur Heart J Cardiovasc Im-aging. 2014 Oct;15(10):1108-16.
13. Takotsubo cardiomyopathy: an integrated multi-imaging approach. Bossone E, Lyon A, Citro R, Athanasiadis A, Meimoun P, Parodi G, Cimarelli S, Omerovic E, Ferrara F, Limongelli G, Cittadini A, Salerno-Uriarte JA, Perrone Filardi P, Schneider B, Sechtem U, Erbel R. Eur Heart J Cardiovasc Imaging. 2014 Apr;15(4):366-77.
14. Evaluation of the accuracy of gadolinium-enhanced CMR in the diagnosis of cardiac sarcoidosis. Smedema JP et al. J Am Coll Cardiol. 2005;45:1683-90.
15. Importance of CMR within the Task Force Criteria for the diagnosis of ARVC in chil-dren and adolescents. Etoom Y, Govindapillai S, Hamilton R, Manlhiot C, Yoo SJ, Far-han M, Sarikouch S, Peters B, McCrindle BW, Grosse-Wortmann L. J Am Coll Cardiol. 2015 Mar 17;65(10):987-95. doi: 10.1016/j.jacc.2014.12.041.
16. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Ab-del-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87. doi: 10.1016/j.jacc.2009.02.007.
17. European Association of Cardiovascular Imaging (EACVI) position paper: multimo-dality imaging in pericardial disease. Cosyns B, Plein S, Nihoyanopoulos P, Smiseth O, Achenbach S, Andrade MJ, Pepi M, Ristic A, Imazio M, Paelinck B, Lancellotti P; On behalf of the European Association of Cardiovascular Imaging (EACVI) and European Society of Cardiology Working Group (ESC WG) on Myocardial and Pericardial diseas-es. Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):12-31.
18. Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values. Burman ED, Keegan J, Kil-ner PJ. Circ Cardiovasc Imaging. 2008 Sep;1(2):104-13. doi: 10.1161/CIRCIMAGING.108.768911.
19. Pulmonary artery diameters, cross sectional areas and area changes measured by cine cardiovascular magnetic resonance in healthy volunteers. Burman ED, Keegan J, Kilner PJ. J Cardiovasc Magn Reson. 2016 Mar 3;18:12. doi: 10.1186/s12968-016-0230-9.
20. 4D flow cardiovascular magnetic resonance consensus statement. Dyverfeldt P, Bissell M, Barker AJ, Bolger AF, Carlhäll CJ, Ebbers T, Francios CJ, Frydrychowicz A, Geiger J, Giese D, Hope MD, Kilner PJ, Kozerke S, Myerson S, Neubauer S, Wieben O, Markl M. J Cardiovasc Magn Reson. 2015 Aug 10;17(1):72. doi: 10.1186/s12968-015-0174-5.
21. Heart valve disease: investigation by cardiovascular magnetic resonance. Myerson SG. J Cardiovasc Magn Reson. 2012 Jan 19;14:7. doi: 10.1186/1532-429X-14-7.
22. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Cawley PJ, Maki JH, Otto CM. Circulation. 2009 Jan 27;119(3):468-78. doi: 10.1161/CIRCULATIONAHA.107.742486.
23. Indications for cardiovascular magnetic resonance in children with congenital and ac-quired heart disease: an expert consensus paper of theImaging Working Group of the AEPC and the Cardiovascular MagneticResonance Section of the EACVI. Valsangiaco-mo Buechel ER, Grosse-Wortmann L, Fratz S, Eichhorn J, Sarikouch S, Greil GF, Beerbaum P, Bucciarelli-Ducci C, Bonello B, Sieverding L, Schwitter J, Helbing WA; EACVI, Galderisi M, Miller O, Sicari R, Rosa J, Thaulow E, Edvardsen T, Brockmeier K, Qureshi S, Stein J. Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):281-97. doi: 10.1093/ehjci/jeu129. Epub 2015 Feb 17.
24. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER, Yoo SJ, Powell AJ. J Cardiovasc Magn Reson. 2013 Jun 13;15:51. doi: 10.1186/1532-429X-15-51.
25. Extra-cardiac findings in cardiovascular magnetic resonance: what the imaging cardi-ologist needs to know. Rodrigues JC, Lyen SM, Loughborough W, Amadu AM, Baritus-sio A, Dastidar AG, Manghat NE, Bucciarelli-Ducci C. J Cardiovasc Magn Reson. 2016 May 9;18(1):26. doi: 10.1186/s12968-016-0246-1.
26. Incidental extra-cardiac findings on clinical CMR. Irwin RB, Newton T, Peebles C, Borg A, Clark D, Miller C, Abidin N, Greaves M, Schmitt M. Eur Heart J Cardiovasc Imaging. 2013 Feb;14(2):158-66. doi: 10.1093/ehjci/jes133.